AI generated summary of Pubmed citation/abstract with PMID 38093213

https://pubmed.ncbi.nlm.nih.gov/38093213

The non-invasive Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) scoring system, MAFLD-S, accurately identifies MAFLD in inflammatory bowel disease patients, aiding in the assessment of hepatic steatosis and metabolic risk factors.